Michael Kresken, Béatrice Grabein, Karsten Becker, Eberhard Straube, Thomas A Wichelhaus, Birgit Willinger
{"title":"Calculated parenteral initial treatment of bacterial infections: Microbiology.","authors":"Michael Kresken, Béatrice Grabein, Karsten Becker, Eberhard Straube, Thomas A Wichelhaus, Birgit Willinger","doi":"10.3205/id000062","DOIUrl":null,"url":null,"abstract":"<p><p>This is the second chapter of the guideline \"Calculated initial parenteral treatment of bacterial infections in adults - update 2018\" in the 2<sup>nd</sup> updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Preliminary microbiological findings regarding the patient and their immediate environment are crucial for the calculation of treatment with antibiotics in each case, as well as the resistance situation of the ward on which the patient is being cared for. If such data is not available, regional or supra-regional data can be used as a fallback. This chapter describes the methods of susceptibility testing, informs about the resistance situation in Germany and describes the main resistance mechanisms of bacterial pathogens against antibiotics. Further, the chapter informs about collateral damage of antibiotics as well as medical measures against increasing resistance.</p>","PeriodicalId":91688,"journal":{"name":"GMS infectious diseases","volume":"8 ","pages":"Doc18"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186810/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS infectious diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3205/id000062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This is the second chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2nd updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Preliminary microbiological findings regarding the patient and their immediate environment are crucial for the calculation of treatment with antibiotics in each case, as well as the resistance situation of the ward on which the patient is being cared for. If such data is not available, regional or supra-regional data can be used as a fallback. This chapter describes the methods of susceptibility testing, informs about the resistance situation in Germany and describes the main resistance mechanisms of bacterial pathogens against antibiotics. Further, the chapter informs about collateral damage of antibiotics as well as medical measures against increasing resistance.
这是《成人细菌感染的初始肠外治疗计算指南--2018 年更新版》第二次更新版中的第二章。由保罗-埃利希化疗协会(Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.,PEG)制定的德国指南已被翻译成国际版本。有关患者及其周围环境的初步微生物学研究结果对于计算每个病例的抗生素治疗方案以及患者所在病房的抗药性情况至关重要。如果无法获得此类数据,则可以使用地区或超地区数据作为备用。本章介绍了药敏试验的方法,通报了德国的耐药性情况,并描述了细菌病原体对抗生素的主要耐药机制。此外,本章还介绍了抗生素的附带损害以及应对抗药性增加的医疗措施。